February 3, 2025
Update: Jefferies reportedly mandated for upcoming auction process for Swixx Biopharma, a distributor of rare diseases prescription- and OTC medicines backed by Merieux Equity Partners since 2021, 2024 EBITDA of around EUR 85m, acc. to sources (NKP | M&A Insights Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights